Botanix Pharmaceuticals Limited announced the appointment of two highly qualified global pharmaceutical industry executives to expand the company's clinical development capabilities. The company appointed Dr. Stephane Levy as Chief Medical Officer and Ms Jillian Chapas-Reed as Senior Director of Clinical Operations. Dr. Levy brings significant experience having most recently been the Vice-President of Research and Development at global dermatology company Almirall's US subsidiary Aqua Pharmaceuticals. Ms Chapas-Reed also brings significant experience in both clinical trial management and dermatology and joins Botanix from Churchill Pharmaceuticals (Churchill) where she most recently led a Phase 2/3 study that was successfully approved by the FDA in May 2018.